| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
218,850,000 |
| Market
Cap: |
39.94(B) |
| Last
Volume: |
90,505,923 |
Avg
Vol: |
10,473,413 |
| 52
Week Range: |
$182.5 - $182.5 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mathis Larry |
Director |
– • – |
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
895 |
30,351 |
|
- |
|
| Norby R Douglas |
Director |
– • – |
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
895 |
32,676 |
|
- |
|
| Bell Leonard |
CEO |
• • – |
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
10,100 |
1,032,331 |
|
- |
|
| Squinto Stephen P |
EVP, Chief Global Ops. Officer |
• – – |
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
108,606 |
|
- |
|
| Parven Alvin S |
Director |
– • – |
2014-02-11 |
4 |
S |
$174.06 |
$430,102 |
D/D |
(2,471) |
4,840 |
|
- |
|
| Squinto Stephen P |
EVP, Chief Global Ops. Officer |
• – – |
2014-02-10 |
4 |
S |
$167.31 |
$273,552 |
D/D |
(1,635) |
101,308 |
|
- |
|
| Sinha Vikas |
EVP & CFO |
• – – |
2014-02-07 |
4 |
S |
$155.55 |
$252,029 |
D/D |
(1,620) |
137,900 |
|
- |
|
| Madri Joseph A |
Director |
– • – |
2014-02-07 |
4 |
S |
$159.00 |
$4,770,000 |
D/D |
(30,000) |
179,217 |
|
- |
|
| Madri Joseph A |
Director |
– • – |
2014-02-07 |
4 |
OE |
$4.93 |
$147,900 |
D/D |
30,000 |
209,217 |
|
- |
|
| Moriarty John B |
SVP & General Counsel |
• – – |
2014-02-07 |
4 |
S |
$155.55 |
$161,198 |
D/D |
(1,036) |
22,232 |
|
- |
|
| Squinto Stephen P |
EVP, Chief Global Ops. Officer |
• – – |
2014-02-07 |
4 |
S |
$155.55 |
$252,030 |
D/D |
(1,620) |
102,943 |
|
- |
|
| Hallal David |
EVP, Chief Commercial Officer |
• – – |
2014-02-07 |
4 |
S |
$155.55 |
$250,461 |
D/D |
(1,610) |
113,965 |
|
- |
|
| Bell Leonard |
CEO |
• • – |
2014-02-07 |
4 |
S |
$155.55 |
$718,672 |
D/D |
(4,620) |
986,696 |
|
- |
|
| Carmichael Clare |
SVP, Chief HR Officer |
• – – |
2014-02-07 |
4 |
S |
$155.55 |
$156,496 |
D/D |
(1,006) |
13,765 |
|
- |
|
| Wright Frank J |
SVP, President Alxn Pharm Intl |
• – – |
2014-02-07 |
4 |
S |
$155.55 |
$170,819 |
D/D |
(1,098) |
19,670 |
|
- |
|
| Sinha Vikas |
EVP & CFO |
• – – |
2014-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
9,745 |
139,520 |
|
- |
|
| Moriarty John B |
SVP & General Counsel |
• – – |
2014-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
6,068 |
23,268 |
|
- |
|
| Squinto Stephen P |
EVP, Chief Global Ops. Officer |
• – – |
2014-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
9,745 |
104,563 |
|
- |
|
| Squinto Stephen P |
EVP, Chief Global Ops. Officer |
• – – |
2014-02-06 |
4 |
S |
$155.11 |
$589,418 |
D/D |
(3,800) |
94,818 |
|
- |
|
| Squinto Stephen P |
EVP, Chief Global Ops. Officer |
• – – |
2014-02-06 |
4 |
OE |
$93.83 |
$356,554 |
D/D |
3,800 |
98,618 |
|
- |
|
| Hallal David |
EVP, Chief Commercial Officer |
• – – |
2014-02-06 |
4 |
S |
$156.95 |
$1,570 |
D/D |
(10) |
113,965 |
|
- |
|
| Hallal David |
EVP, Chief Commercial Officer |
• – – |
2014-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
9,745 |
115,575 |
|
- |
|
| Bell Leonard |
CEO |
• • – |
2014-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
28,040 |
991,316 |
|
- |
|
| Carmichael Clare |
SVP, Chief HR Officer |
• – – |
2014-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
6,068 |
14,771 |
|
- |
|
| Wright Frank J |
SVP, President Alxn Pharm Intl |
• – – |
2014-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
6,068 |
20,768 |
|
- |
|
1501 Records found
|
|
Page 26 of 61 |
|
|
